Claes Wahlestedt

From Wikipedia, the free encyclopedia

Claes Wahlestedt is a Swedish-American biomedical researcher and entrepreneur. He is a professor at the University of Miami.[1]

He is the inventor of the so-called AntagoNAT oligonucleotide technology, which allows for upregulation of genes in genetic and other disorders.[2][3] A number of small molecule drugs have also been discovered by or under Wahlestedt's direction.[4][5]

Career

References

External links

Related Articles

Wikiwand AI